Chinese pharmaceutical company Sinopharm announced Wednesday that Phase III clinical trials found their Chinese coronavirus vaccine candidate to be 72.51 percent effective in preventing infections. The number is significantly higher than the only Chinese-made vaccine widely approved internationally, "Coronavac" by the company Sinovac, which studies found to be 50.38 percent effective. It is still significantly lower than the vaccines produced by American pharmaceutical companies. Studies show the first vaccine approved by the U.S. Food and Drug Administration (FDA), from Pfizer, to be about 95 percent effective in preventing infections. The second, by the pharmaceutical company Moderna, was found to be about 94.1 percent effective. Chinese state media has repeatedly attacked the Pfizer vaccine, citing Communist Party-approved experts urging the world not to approve it, while declaring Coronavac " good enough ." According to the Chinese state outlet Global Times , the Sinopharm vaccine candidate – tested in Wuhan, the origin location of the Chinese coronavirus – requires two doses to achieve its 72 percent efficacy. It uses inactivated viral cells, a different method than the mRNA process used by Pfizer and Moderna. The Chinese government approved the Sinopharm vaccine on Wednesday. "So far, data from the trials shows that the vaccine… Read full this story
China's 2nd Coronavirus Vaccine Still 20% Less Effective Than Pfizer have 212 words, post on www.breitbart.com at February 24, 2021. This is cached page on Vietnam Art News. If you want remove this page, please contact us.